Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRD007 in Abdominal Aortic Aneurysm
NCT01354184Phase 2Completed
- Sponsor
- RSPR Pharma
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of pemirolast in abdominal aortic aneurysm (AAA) (4 arms), sponsored by RSPR Pharma. Primary endpoint: Change in Abdominal Aortic Aneurysm Diameter at 1 year. Status: completed.
02
Drugs
pemirolast
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NCT01354184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01354184.